Kura Oncology, Inc. (KURA)
9.22
-0.52
(-5.34%)
USD |
NASDAQ |
May 15, 16:00
9.225
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology EPS Diluted (Quarterly) : -0.8276 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Curis, Inc. | -1.250 |
| Novavax, Inc. | -0.0581 |
| Capricor Therapeutics, Inc. | -0.591 |
| Agenus, Inc. | 1.023 |
| LadRx Corp. | -1.453 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -73.33M |
| Revenue (Quarterly) | 18.26M |
| Total Expenses (Quarterly) | 91.60M |
| Enterprise Value | 261.95M |
| Gross Profit Margin (Quarterly) | 96.62% |
| Profit Margin (Quarterly) | -401.5% |
| Earnings Yield | -36.31% |
| Normalized Earnings Yield | -36.31 |